New News information at Practical Patient Care New and updated information from News listed on en-us New News information at Practical Patient Care BD acquires MedKeeper to offer cloud-based pharmacy management solutions by <br/> <br/> The acquisition will complement BD’s technology pharmacy solutions and further advance its smart, customisable, connected care platform to optimise IV workflow Fri, 29 Jul 2022 09:33:00 GMT EC to extend Bavarian Nordic’s Imvanex indication to prevent monkeypox disease by <br/> <br/> Based on the CHMP recommendation, the European Commission (EC) will grant the final approval soon, which will be valid in all the Member States of the European Union (EU) along with Iceland, Liechtenstein, and Norway Mon, 25 Jul 2022 06:10:00 GMT Amazon to acquire primary care provider One Medical for $3.9bn by <br/> <br/> One Medical provides in-person care, along with digital health and virtual care services, allowing patients to schedule appointments, renew prescriptions, access health records Fri, 22 Jul 2022 10:15:00 GMT Bavarian Nordic to supply additional monkeypox shots to US, Europe by <br/> <br/> Jynneos is a liquid-frozen non-replicating smallpox vaccine that has been approved by the US Food and Drug Administration (FDA) as the only vaccine against monkeypox Mon, 18 Jul 2022 06:15:00 GMT Infosys to acquire Danish life science consultancy firm for €110m by <br/> <br/> The acquisition enables Infosys to provide the global life sciences companies with cloud-first digital platforms and data, strengthen its life sciences capabilities and expand its footprint across Europe Thu, 14 Jul 2022 11:20:00 GMT GenScript, ACT Therapeutics partner to develop new CAR-T Cell therapies by <br/> <br/> GenScript ProBio will support ACT therapeutics’ CAR-T Platform (ACT platform), an immune cell-based cell and gene therapy technology that leverages virus vectors to target cancer antigens Wed, 13 Jul 2022 07:13:00 GMT Roche licenses Ionis’ investigational therapy for rare kidney disease by <br/> <br/> Ionis will receive $55m from Roche, in exchange for licensing IONIS-FB-LRx and achieving a development milestone in the GOLDEN study Tue, 12 Jul 2022 07:30:00 GMT Vertex to acquire T1D therapeutics maker ViaCyte for $320m by <br/> <br/> The agreement follows the US Food and Drug Administration (FDA) lifting the clinical hold on the Phase 1/2 clinical trial of VX-880, a T1D therapy developed by Vertex Tue, 12 Jul 2022 07:01:00 GMT ADC Therapeutics, Sobi enter into license deal for Zynlonta by <br/> <br/> As per the agreement, the companies will develop and market Zynlonta for all hematologic and solid tumour indications, outside of the US, Greater China, Singapore and Japan Mon, 11 Jul 2022 10:00:00 GMT SIGA’s Tecovirimat approved in UK to treat complications after smallpox vaccination by <br/> <br/> The UK health regulator indicated Tecovirimat for the treatment of smallpox, monkeypox, cowpox, and vaccinia complications, after vaccination against smallpox in adults and children Mon, 11 Jul 2022 07:43:00 GMT